Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Pharma
Along with CRISPR nod, FDA approves bluebird's SCD gene therapy
The FDA cleared bluebird's SCD gene therapy Lyfgenia and Vertex/CRISPR's CRISPR-based Casgevy at the same time.
Angus Liu
Dec 8, 2023 1:22pm
Amid FDA probe, upcoming adcomm could offer key CAR-T guidance
Nov 29, 2023 1:52pm
FDA probes CAR-T therapies' 'serious risk' of secondary cancer
Nov 28, 2023 1:16pm
RoslinCT scores big with Vertex gene therapy production pact
Nov 28, 2023 2:05am
Novartis-Legend, Astellas, Ajinomoto—Fierce Pharma Asia
Nov 17, 2023 8:00am
Even after primary miss, Sarepta to seek wider Elevidys approval
Oct 30, 2023 5:46pm
More News
Moderna, BioNTech's post-COVID futures hit manufacturing reality
Oct 24, 2023 8:31am
Forge blazes into collaboration to bolster AAV gene therapies
Oct 12, 2023 9:25am
Bayer cuts ribbon at new cell therapy 'launch facility' in CA
Oct 10, 2023 10:51am
Takeda, Kyowa Kirin, Biogen—Fierce Pharma Asia
Oct 6, 2023 8:35am
See more stories
